Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations.
Mark-David LevinArnon P KaterMattias MattssonSabina KerstingJuha RantiHoa Thi Tuyet TranKazem NasserinejadCarsten Utoft NiemannPublished in: BMJ open (2020)
ClinicalTrials.gov Registry (NCT03226301).
Keyphrases
- chronic lymphocytic leukemia
- study protocol
- open label
- clinical trial
- randomized controlled trial
- phase iii
- placebo controlled
- phase ii
- double blind
- acute lymphoblastic leukemia
- acute myeloid leukemia
- multiple myeloma
- diffuse large b cell lymphoma
- hodgkin lymphoma
- copy number
- uric acid
- gene expression
- metabolic syndrome